Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or "the Company"), an oncology-focused drug development company, today announced the sale of all intellectual property and trademarks rights to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback